ArticleJournal of immunology (Baltimore, Md. : 1950)2023

Low-Dose Lipopolysaccharide Protects from Lethal Paramyxovirus Infection in a Macrophage- and TLR4-Dependent Process.

Jenny Resiliac et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.